WallStreetZenWallStreetZen

NASDAQ: APLM
Apollomics Inc Stock Ownership - Who owns Apollomics?

Insider buying vs selling

Have Apollomics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when APLM insiders and whales buy or sell their stock.

APLM Shareholders

What type of owners hold Apollomics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC9.57%8,565,456$3.94MInstitution
Geode Capital Management LLC0.06%57,224$26.32kInstitution
Citadel Advisors LLC0.06%54,722$25.17kInstitution
Exchange Traded Concepts LLC0.04%35,673$16.41kInstitution
Ubs Group Ag0.04%32,136$14.78kInstitution
Bensler LLC0.03%25,088$11.54kInstitution
George Kaiser Family Foundation0.03%24,984$11.49kInstitution
Commonwealth Equity Services LLC0.02%20,000$9.20kInstitution
Zullo Investment Group Inc0.02%14,853$6.83kInstitution
Johnson Johnson0.01%13,252$6.10kInstitution

1 of 2

APLM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLM9.89%0.00%
IMRX53.75%46.25%Net SellingNet Selling
BLRX0.10%0.00%
OCEA13.42%75.32%
AADI26.99%73.01%Net SellingNet Selling

Apollomics Stock Ownership FAQ

Who owns Apollomics?

Apollomics (NASDAQ: APLM) is owned by 9.89% institutional shareholders, 0.00% Apollomics insiders, and 90.11% retail investors. Orbimed Advisors LLC is the largest individual Apollomics shareholder, owning 8.57M shares representing 9.57% of the company. Orbimed Advisors LLC's Apollomics shares are currently valued at $4.03M.

If you're new to stock investing, here's how to buy Apollomics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.